Biotech downturn claims another victim with sweeping Mural Oncology layoffs
The Massachusetts-based firm faces difficult decisions after clinical trial disappointments, raising concerns across the industry. Mural Oncology confirmed Wednesday that it will eliminate about 104 positions, representing roughly 90% of its workforce. The announcement comes in the wake of unsuccessful clinical trials for its melanoma and ovarian cancer treatments, which failed to meet key targets. … Read more